Abstract
A peak in FDA drug approvals came as companies increase their focus on the genetic drivers of disease
Cite
CITATION STYLE
APA
Lisa M. Jarvis. (2020). The new drugs of 2019. C&EN Global Enterprise, 98(3), 30–36. https://doi.org/10.1021/cen-09803-cover
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free